Bioassays

Allows propagation and banking of the ADCC Bioassay, F Variant, Effector Cells

The ADCC Reporter Bioassay provides a biologically relevant and specific MOA-based measure of ADCC without the complex workflow and variability inherent in primary cell-based assays.

The Beta-Glo Assay System is a homogeneous, luminescence-based method for quantitating beta-galactosidase expression in mammalian cells.

The Bio-Glo Luciferase Assay System provides a highly sensitive, robust, homogeneous reagent, the Bio-Glo Assay reagent with a new luciferase substrate, for the detection of firefly luciferase reporter gene expression in the ADCC Reporter Bioassay.

The CTLA-4 Blockade Bioassay reflects the mechanism of action (MOA) of biologics designed to block the interaction of CTLA-4 with its ligands, CD80 and CD86.

An automation-friendly, highly sensitive substrate for Renilla luciferase-based gene reporter and BRET applications.

The FcgammaRIIa-H ADCP Reporter Bioassay is a biologically relevant MOA-based assay that can be used to measure the potency and stability of antibodies and other biologics that specifically bind and activate FcgammaRIIa.

The PD-1/PD-L1 Blockade Bioassay is a biologically relevant MOA-based assay that can be used to measure the potency and stability of antibodies and other biologics designed to block the PD-1/PD-L1 interaction.

The T Cell Activation Bioassay, Propagation Model, provides a biologically relevant and specific MOA-based measure of TCR/CD3 Effector Cells without the complex workflow and variability inherent in primary cell-based assays.

The T Cell Activation Bioassay, Propagation Model, provides a biologically relevant and specific MOA-based measure of TCR/CD3 Effector Cells without the complex workflow and variability inherent in primary cell-based assays.

10mM each nucleotide in water